Strength
5 mg/mL
Manufacturer
AvPAKNDC
50268006750
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CARBOXYMETHYLCELLULOSE SODIUMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
11/19/2020
Price Statistics
The NADAC for CARBOXYMETHYLCELL 0.5% EYE DRP has been published 33 times since Feb 18, 2026, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2548 per EA |
|---|---|
| All-time high | $0.2584 (Jul 15, 2026) |
| All-time low | $0.2486 (Feb 18, 2026) |
| 52-week high | $0.2584 |
| 52-week low | $0.2486 |
| Median price | $0.2548 |
| Average price | $0.2535 |
| Largest weekly change | +1.8% (Apr 22, 2026) |
| Weeks tracked | 33 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
carboxymethylcellulose sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARBOXYMETHYLCELL 0.5% EYE DRP?
The current National Average Drug Acquisition Cost (NADAC) for CARBOXYMETHYLCELL 0.5% EYE DRP, manufactured by AvPAK, is $0.2548 per EA (NDC 50268006750), effective Sep 30, 2026.
How has the price of CARBOXYMETHYLCELL 0.5% EYE DRP changed over time?
Over the history we have for it, the NADAC for CARBOXYMETHYLCELL 0.5% EYE DRP has risen 2.5%. It has been tracked across 33 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for CARBOXYMETHYLCELL 0.5% EYE DRP?
Since Feb 18, 2026, the NADAC for CARBOXYMETHYLCELL 0.5% EYE DRP has ranged from a low of $0.2486 (Feb 18, 2026) to a high of $0.2584 (Jul 15, 2026), with a median of $0.2548 per EA.
Are there cheaper alternatives to CARBOXYMETHYLCELL 0.5% EYE DRP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBOXYMETHYLCELL 0.5% EYE DRP, is $0.1628 per EA — about 36% below CARBOXYMETHYLCELL 0.5% EYE DRP.
Who manufactures CARBOXYMETHYLCELL 0.5% EYE DRP?
CARBOXYMETHYLCELL 0.5% EYE DRP (NDC 50268006750) is labeled by AvPAK, and CMS classifies it as a generic product.